Biocytogen

Biocytogen is a global biotechnology company specializing in the development of innovative therapeutics through advanced gene-editing technologies and the generation of preclinical animal models. Their proprietary platforms, including the RenMice family for fully human antibody discovery and custom gene-editing services, facilitate drug development across various therapeutic areas such as oncology, immunology, and more. By providing ready-to-use drug-targeted humanized models and comprehensive pharmacology services, Biocytogen accelerates the drug discovery process from target identification to IND submission.